Indrani Lall Franchini, EVP, Chief Compliance Officer at ALEXION PHARMACEUTICALS, INC. (ALXN), sold 4,500 shares at $132.78 ($598K) on 2019-07-01, disclosed to the SEC on 2019-07-02.
Open-market sale of $598k ALXN by EVP, Chief Compliance Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ALNY | SELL | 2023-04-10 | $735K | — | Filing → |
| ALNY | SELL | 2023-02-03 | $739K | — | Filing → |
| ALXN | SELL | 2020-06-09 | $1.4M | — | Filing → |